{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:33:31Z","timestamp":1791920011510,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Complementary Therapies in Medicine"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.ctim.2016.04.002","type":"journal-article","created":{"date-parts":[[2016,4,9]],"date-time":"2016-04-09T20:30:59Z","timestamp":1460233859000},"page":"171-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Efficacy and safety of Ayurvedic herbs in diarrhoea-predominant irritable bowel syndrome: A randomised controlled crossover trial"],"prefix":"10.1016","volume":"26","author":[{"given":"Romy","family":"Lauche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syal","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Hallmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"L\u00fcdtke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Rampp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustav","family":"Dobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jost","family":"Langhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctim.2016.04.002_bib0005","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cgh.2012.02.029","article-title":"Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis","volume":"10","author":"Lovell","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ctim.2016.04.002_bib0010","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/MCG.0b013e318247157c","article-title":"A global perspective on irritable bowel syndrome: a consensus statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel syndrome","volume":"46","author":"Quigley","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.ctim.2016.04.002_bib0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1443-9573.2006.00265.x","article-title":"Rome III: the new criteria","volume":"7","author":"Drossman","year":"2006","journal-title":"Chin J Dig Dis"},{"key":"10.1016\/j.ctim.2016.04.002_bib0020","first-page":"237","article-title":"New standard for functional gastrointestinal disorders","volume":"15","author":"Drossman","year":"2006","journal-title":"J Gastrointest Liver Dis"},{"key":"10.1016\/j.ctim.2016.04.002_bib0025","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ctim.2016.04.002_bib0030","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1001\/jama.280.18.1585","article-title":"Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial","volume":"280","author":"Bensoussan","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ctim.2016.04.002_bib0035","first-page":"705","article-title":"Complementary and alternative medicine modalities for the treatment of irritable bowel syndrome: facts or myths","volume":"6","author":"Wu","year":"2010","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.ctim.2016.04.002_bib0040","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/j.1572-0241.2003.07519.x","article-title":"Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey","volume":"98","author":"Hilsden","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ctim.2016.04.002_bib0045","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/01.MIB.0000160771.71328.6c","article-title":"Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey","volume":"11","author":"Langhorst","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ctim.2016.04.002_bib0050","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1472-6882-8-46","article-title":"Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO","volume":"8","author":"van Tilburg","year":"2008","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/j.ctim.2016.04.002_bib0055","doi-asserted-by":"crossref","first-page":"e446","DOI":"10.1542\/peds.2008-0266","article-title":"Use of complementary and alternative medicine by pediatric patients with functional and organic gastrointestinal diseases: results from a multicenter survey","volume":"122","author":"Vlieger","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.ctim.2016.04.002_bib0060","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1111\/j.1572-0241.2006.00576.x","article-title":"Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial","volume":"101","author":"Leung","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ctim.2016.04.002_bib0065","series-title":"Seminar Papers-2007 Irritable Bowel Syndrom","author":"Nayar","year":"2007"},{"key":"10.1016\/j.ctim.2016.04.002_bib0070","unstructured":"Nistesvar K, Vidyabath R. Sahasrayogam: text with English translation. Varanasi: Chowkhamba Sanskrit Series Office; 2006."},{"key":"10.1016\/j.ctim.2016.04.002_bib0075","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1055\/s-0029-1245976","article-title":"Irritable bowel syndrome: German consensus guidelines on definition, pathophysiology and management","volume":"49","author":"Layer","year":"2011","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.ctim.2016.04.002_bib0080","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2036.1997.142318000.x","article-title":"The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress","volume":"11","author":"Francis","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ctim.2016.04.002_bib0085","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/ajg.2011.201","article-title":"Severity in irritable bowel syndrome: a Rome Foundation Working Team report","volume":"106","author":"Drossman","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ctim.2016.04.002_bib0090","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1524-4733.2006.00086.x","article-title":"Performance of the EQ-5D in patients with irritable bowel syndrome","volume":"9","author":"Bushnell","year":"2006","journal-title":"Value Health"},{"key":"10.1016\/j.ctim.2016.04.002_bib0095","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11136-011-9915-6","article-title":"Validation of the EQ-5D in a general population sample in urban China","volume":"21","author":"Wang","year":"2012","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ctim.2016.04.002_bib0100","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1572-0241.2000.01941.x","article-title":"Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire","volume":"95","author":"Drossman","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ctim.2016.04.002_bib0105","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1023\/A:1018831127942","article-title":"Quality of life in persons with irritable bowel syndrome: development and validation of a new measure","volume":"43","author":"Patrick","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ctim.2016.04.002_bib0110","series-title":"Hospital Anxiety and Depression Scale\u2014Deutsche Version (HADS-D)","author":"Hermann","year":"1995"},{"key":"10.1016\/j.ctim.2016.04.002_bib0115","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/030006059802600203","article-title":"Adequate relief as an endpoint in clinical trials in irritable bowel syndrome","volume":"26","author":"Mangel","year":"1998","journal-title":"J Int Med Res"},{"key":"10.1016\/j.ctim.2016.04.002_bib0120","first-page":"496","article-title":"Irritable bowel syndrome: therapeutic evaluation of indigenous drugs","volume":"90","author":"Yadav","year":"1989","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.ctim.2016.04.002_bib0125","series-title":"Clinical Management of Irritable Bowel Syndrome (IBS) Through Takra Vasti and Sangrahi Vasti","author":"Ragavendran","year":"2011"},{"key":"10.1016\/j.ctim.2016.04.002_bib0130","series-title":"Randomisierte, placebokontrollierte, klinische Doppelblindstudie zur Pr\u00fcfung der Wirksamkeit eines pflanzlichen Kombinationspr\u00e4parates aus der ayurvedischen Medizin bei Patienten mit Colon irritable","author":"Saha","year":"1998"},{"key":"10.1016\/j.ctim.2016.04.002_bib0135","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1080\/00365520510023134","article-title":"Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome: a randomized, placebo-controlled, double-blind clinical trial","volume":"40","author":"Brinkhaus","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ctim.2016.04.002_bib0140","first-page":"A380","article-title":"Complementary medicine in irritable bowel syndrome a randomised double blind, placebo-controlled trial","author":"Hentschel","year":"1996","journal-title":"Dig Dis Week"},{"key":"10.1016\/j.ctim.2016.04.002_bib0145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10354-012-0169-x","article-title":"STW 5 (Iberogast(R))\u2014a safe and effective standard in the treatment of functional gastrointestinal disorders","volume":"163","author":"Ottillinger","year":"2013","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.ctim.2016.04.002_bib0150","series-title":"Irritable Bowel Syndrome in Adults: Diagnosis and Management of Irritable Bowel Syndrome in Primary","author":"National Collaborating Centre for Nursing and Supportive Care (UK)","year":"2008"},{"key":"10.1016\/j.ctim.2016.04.002_bib0155","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1053\/j.gastro.2005.11.058","article-title":"Design of treatment trials for functional gastrointestinal disorders","volume":"130","author":"Design of Treatment Trials","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ctim.2016.04.002_bib0160","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/RHU.0b013e31821c0310","article-title":"Double-blind, randomized, controlled, pilot study comparing classic ayurvedic medicine, methotrexate, and their combination in rheumatoid arthritis","volume":"17","author":"Furst","year":"2011","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.ctim.2016.04.002_bib0165","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1078\/0944-7113-00095","article-title":"The evaluation of the radioprotective effect of Triphala (an ayurvedic rejuvenating drug) in the mice exposed to gamma-radiation","volume":"9","author":"Jagetia","year":"2002","journal-title":"Phytomedicine"}],"container-title":["Complementary Therapies in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229916300528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229916300528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:07:14Z","timestamp":1760807234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0965229916300528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":33,"alternative-id":["S0965229916300528"],"URL":"https:\/\/doi.org\/10.1016\/j.ctim.2016.04.002","relation":{},"ISSN":["0965-2299"],"issn-type":[{"value":"0965-2299","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of Ayurvedic herbs in diarrhoea-predominant irritable bowel syndrome: A randomised controlled crossover trial","name":"articletitle","label":"Article Title"},{"value":"Complementary Therapies in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctim.2016.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}